Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species.
暂无分享,去创建一个
[1] M. Lim,et al. Metal-associated amyloid-β species in Alzheimer's disease. , 2012, Current opinion in chemical biology.
[2] Ayyalusamy Ramamoorthy,et al. Misfolded proteins in Alzheimer's disease and type II diabetes. , 2012, Chemical Society reviews.
[3] A. Ramamoorthy,et al. Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species. , 2011, Inorganic chemistry.
[4] C. Masters,et al. The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity , 2011, Journal of neurochemistry.
[5] Alaina S. DeToma,et al. Myricetin: A Naturally Occurring Regulator of Metal‐Induced Amyloid‐β Aggregation and Neurotoxicity , 2011, Chembiochem : a European journal of chemical biology.
[6] Changlin Liu,et al. The chelation targeting metal-Aβ40 aggregates may lead to formation of Aβ40 oligomers. , 2011, Dalton transactions.
[7] T. Storr,et al. N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy , 2011 .
[8] M. Lim,et al. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation. , 2011, Metallomics : integrated biometal science.
[9] G. Perry,et al. Role of metal dyshomeostasis in Alzheimer's disease. , 2011, Metallomics : integrated biometal science.
[10] Ann Tiiman,et al. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. , 2011, Metallomics : integrated biometal science.
[11] J. Shearer,et al. Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers. , 2010, Chemical communications.
[12] R. Nanga,et al. Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity , 2010, Proceedings of the National Academy of Sciences.
[13] H. Tamura,et al. An effective synthesis of 5,4'-disubstituted flavones via a cesium enolate assisted intramolecular ipso-substitution reaction. , 2010, Chemical & pharmaceutical bulletin.
[14] K. Blennow,et al. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.
[15] K. Lee,et al. Naturally occurring phytochemicals for the prevention of Alzheimer’s disease , 2010, Journal of neurochemistry.
[16] K. Franz,et al. Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. , 2010, Dalton transactions.
[17] Xinyu Jiang,et al. Effect of Zinc (II) on the interactions of bovine serum albumin with flavonols bearing different number of hydroxyl substituent on B-ring. , 2010, Journal of inorganic biochemistry.
[18] Peter Faller,et al. Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer , 2009, Chembiochem : a European journal of chemical biology.
[19] A. Ramamoorthy,et al. Small molecule modulators of copper-induced Abeta aggregation. , 2009, Journal of the American Chemical Society.
[20] P. Faller,et al. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. , 2009, Biochimie.
[21] A. Rauk. The chemistry of Alzheimer's disease. , 2009, Chemical Society reviews.
[22] C. Orvig,et al. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. , 2009, Chemical reviews.
[23] H. Jacobsen,et al. Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.
[24] H. Saji,et al. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. , 2009, Bioorganic & medicinal chemistry.
[25] P. Faller,et al. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. , 2009, Dalton transactions.
[26] J. Vidal-Gancedo,et al. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. , 2009, Journal of the American Chemical Society.
[27] P. Chou,et al. Dual excited-state intramolecular proton transfer reaction in 3-hydroxy-2-(pyridin-2-yl)-4H-chromen-4-one. , 2009, The journal of physical chemistry. A.
[28] A. Bush,et al. Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents* , 2008, Journal of Biological Chemistry.
[29] K. Karlin,et al. Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes. , 2008, Angewandte Chemie.
[30] C. Masters,et al. Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.
[31] Ashley I. Bush,et al. Therapeutics for Alzheimer’s disease based on the metal hypothesis , 2008, Neurotherapeutics.
[32] S. Mazères,et al. Thioflavin Derivatives as Markers for Amyloid‐β Fibrils: Insights into Structural Features Important for High‐Affinity Binding , 2008, ChemMedChem.
[33] J. Danielsson,et al. Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes , 2007, Journal of biomolecular NMR.
[34] H. Schugar,et al. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. , 2007, Angewandte Chemie.
[35] Kenjiro Ono,et al. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. , 2007, Biochemistry.
[36] B. Meunier,et al. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes. , 2006, Journal of inorganic biochemistry.
[37] H. Kozłowski,et al. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). , 2006, Chemical reviews.
[38] Ehud Gazit,et al. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.
[39] Masahiro Ono,et al. Radioiodinated Flavones for in Vivo Imaging of β-Amyloid Plaques in the Brain , 2005 .
[40] A. Bush,et al. The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.
[41] Xudong Huang,et al. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis , 2004, Experimental Gerontology.
[42] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[43] Xudong Huang,et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.
[44] D. Selkoe,et al. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics , 2002, Science.
[45] Rui M. Rocha,et al. Interactions of Flavonoids with Iron and Copper Ions: A Mechanism for their Antioxidant Activity , 2002, Free radical research.
[46] C. Masters,et al. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.
[47] Pickett,et al. Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.
[48] M B Katan,et al. Dietary flavonoids: intake, health effects and bioavailability. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[49] C. Rice-Evans,et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.
[50] P. Gans,et al. Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species , 1999 .
[51] D. Craik,et al. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.
[52] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[53] D. S. Garrett,et al. Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. , 1997, Biochemistry.
[54] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[55] S. Grzesiek,et al. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase , 1996, Nature Structural Biology.
[56] D. F. Kelley,et al. Proton transfer dynamics in substituted 3‐hydroxyflavones: Solvent polarization effects , 1993 .
[57] W. Jahnke,et al. Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIA , 1998, Journal of biomolecular NMR.
[58] C. Rice-Evans,et al. Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.